Compare BFRI & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFRI | FOFO |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 19.2M |
| IPO Year | 2021 | 2025 |
| Metric | BFRI | FOFO |
|---|---|---|
| Price | $0.89 | $2.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 484.2K | 195.5K |
| Earning Date | 11-11-2026 | 12-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,705,000.00 | N/A |
| Revenue This Year | $10.65 | N/A |
| Revenue Next Year | $15.88 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $0.57 | $1.70 |
| 52 Week High | $1.66 | $18.50 |
| Indicator | BFRI | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 31.47 | 47.60 |
| Support Level | $0.85 | $1.76 |
| Resistance Level | $0.97 | $2.83 |
| Average True Range (ATR) | 0.08 | 0.26 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 7.11 | 25.23 |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.